Cited by 36Cardiovascular Disease and AdiposityAdipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins

Obesity and Coronary Artery Disease: An Updated Systematic Review 2022

Open access
Manoharan, Mohana Priya, Raja, Rabab, Jamil, Aneeque, Csendes, Denise, Gutlapalli, Sai Dheeraj, Prakash, Keerthana, Swarnakari, Kiran Maee, Bai, Meena +3 more·2022·Cureus

Abstract

The primary goal is to identify the pathogenesis of cardiovascular illnesses in obese patients. Articles were extracted using the MeSH search approach from PubMed and Google Scholar databases. Inclusion and exclusion criteria were used, and duplicates were eliminated. Eight publications were finally included in this research study after two authors independently completed the quality check appraisal. Seven observational studies and one narrative review were found in our search. The publications evaluated the risk of coronary artery disease in metabolically healthy obese people with that of unhealthy obese adults and evaluated the effects of adipose tissue-mediated inflammation. Additionally, they offered several explanations for the obesity problem. Studies have indicated that adipocytokines and their pro-inflammatory cytokines have significantly affected the development of cardiovascular disease in obese subjects. The relationship between metabolically unhealthy people with increased risk for coronary artery disease (CAD) is unclear. It has also been shown that metabolically healthy obese persons are still at risk for developing coronary artery disease (CAD), as explained in certain studies in which inflammation plays a vital role in obese people. There hasn't been much data on the advantages of being physically active in overweight people, but obese people have to change their lifestyle as a first measure.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7759/cureus.29480

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Given existing evidence that even non-MetS obese individuals face elevated cardiovascular risk, these false positives may represent a clinically meaningful subgroup who could benefit from earlier lifestyle or medical interventions.

    “Given existing evidence that even non-MetS obese individuals face elevated cardiovascular risk [43–45], these so-called “false positives” may represent a clinically meaningful subgroup who could benefit from earlier lifestyle or medical interventions.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [18]Metabolic syndrome J Cardiovasc Pharmacol Ther Sherling DH Perumareddi P Hennekens CH 365 367 22 2017 28587579

Cited by

Sorted by citations

Authors
Manoharan, M. P., Raja, R., Jamil, A., Csendes, D., Gutlapalli, S. D., Prakash, K., Swarnakari, K. M., Bai, M., Desai, D. M., Desai, A., & Penumetcha, S. S.
Affiliations
University of California, Riverside (US)
Corresponding author
Manoharan, Mohana Priya
Venue
Cureus
Published
2022-09-23
Volume
14
Issue
9
Pages
e29480-e29480
ISSN
2168-8184 (ISSN-L)
OpenAlex
W4297002008
Cited by
36
References
31
Citations by year
2026: 1 · 2025: 14 · 2024: 14 · 2023: 7
FWCI
1.78
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Cureus (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
obesity, coronary artery disease, metabolically healthy obesity, metabolically unhealthy obesity, adipose tissue inflammation, adipokines, inflammatory cytokines, cardiovascular risk, physical activity, lifestyle modification

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review